Breakdown of Trimethylamine via Trimethylamine Dehydrogenase to Minimize Heart Disease Caused by Red Meat Consumption
Acknowledgements
We’d like to give a special thanks to Anjana Rao and Jerry Lio of the Rao lab at the La Jolla Institute of Allergy and Immunology for their incredible help in the project planning and for mentoring us on some of the technical issues that we faced during our experimentation. We’d also like to thank all the UCSD professors and interviewees that greatly expanded our perspective on this project and gave us a deeper insight into how we could expand our project. The amazing, collaborative work that we were able to achieve demonstrates the interconnected nature of science, we could not have done this without you.
University of California San Diego
Torrey Pines High School
La Jolla Institute for Immunology
Integrated DNA Technologies
Intuit
References
- https://2018.igem.org/Team:TAS_Taipei/Software
- Basran J, Sutcliffe MJ, Scrutton NS. Optimizing the Michaelis Complex of Trimethylamine Dehydrogenase. 2001. The Journ. Of Biol. Chem. 276: 42887-42892.
- Hoyles, Lesley, et al. “Metabolic Retroconversion of Trimethylamine N -Oxide and the Gut Microbiota.” Microbiome, BioMed Central, 20 Apr. 2018, microbiomejournal.biomedcentral.com/articles/10.1186/s40168-018-0461-0.
- Sanghani PC, Stone CL, Ray BD, Pindel EV, Hurley TD, Bosron WF. Kinetic Mechanism of Human Glutathione-Dependent Formaldehyde Dehydrogenase. 2000. Biochemistry. 39(35):10720-10729.
- Uotila L and Koivusalo M. Formaldehyde Dehydrogenase from Human Liver. 1974. The Journ. Of Biol. Chem. 249(23):7653-7663
- Burgess, Selena G., et al. “Probing the Dynamic Interface between Trimethylamine Dehydrogenase (TMADH) and Electron Transferring Flavoprotein (ETF) in the TMADH−2ETF Complex: Role of the Arg-α237 (ETF) and Tyr-442 (TMADH) Residue Pair†,‡.” Biochemistry, vol. 47, no. 18, 12 Apr. 2008, pp. 5168–5181., doi:10.1021/bi800127d.
- Liao, Yuanping, et al. “Structure of Formaldehyde Dehydrogenase from Pseudomonas Aeruginosa: the Binary Complex with the Cofactor NAD+.” Acta Crystallographica. Section F, Structural Biology and Crystallization Communications, International Union of Crystallography, Sept. 2013, www.ncbi.nlm.nih.gov/pmc/articles/PMC3758142/.
- Janeiro, Manuel H, et al. “Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target.” Nutrients, MDPI, 1 Oct. 2018, www.ncbi.nlm.nih.gov/pmc/articles/PMC6213249/.
- Wang, Zeneng, et al. “Non-Lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis.” Cell, vol. 163, no. 7, 17 Dec. 2015, pp. 1585–1595., doi:10.1016/j.cell.2015.11.055.
- NIH. “Atherosclerosis.” National Heart Lung and Blood Institute, U.S. Department of Health and Human Services, 2018, www.nhlbi.nih.gov/health-topics/atherosclerosis.
- Centers for Disease Control and Prevention. “Heart Disease Facts & Statistics.” Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 28 Nov. 2017, www.cdc.gov/heartdisease/facts.htm.